Personal care will lead phenylbenzimidazole sulfonic acid sales through 2036 with 54.3% share of the end-user industry segment in 2026, driven by demand for specialized personal care applications. The market was valued at USD 127.80 billion in 2025 and is expected to be worth USD 255.49 billion by 2036.